Clinical Trial Update: Dexmedetomidine and HIPEC [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for dexmedetomidine combined with HIPEC spanning Phase 2 and Phase 3; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Inflammation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of British Columbia | Conditions: Inflammation, Cancer | Phase 2, Phase 3 | Status: UNKNOWN